A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer. - Tang S; Sethunath V; Metaferia NY; Nogueira MF; Gallant DS; Garner ER; Lairson LA; Penney CM; Li J; Gelbard MK; Alaiwi SA; Seo JH; et al. (Cell reports, 2022)